Cancer is smart and ever-evolving. The same is true of our approach to attacking cancer. We collaborate with an extraordinary group of scientists, physicians, industry peers and patients to continually improve our understanding of cancer. Together, we work to tackle the toughest challenges in oncology.

For over 20 years, we’ve recognized that the best science comes from the best scientists. Together with our partners, we work to develop first-in-class medicines that aim to transform the way cancer is treated. We know that the introduction of new medicines is a significant milestone for cancer patients. And, it’s one of the reasons why our scientists and researchers continually push ahead to develop and deliver the latest breakthroughs in cancer treatment.